Actuate Therapeutics (ACTU) Operating Expenses (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Operating Expenses of $4.7 million for Q4 2025, down 28.52% year-over-year from $6.6 million in Q4 2024, and down 14.32% quarter-over-quarter from $5.5 million in Q3 2025.
Actuate Therapeutics (ACTU) Operating Expenses (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Operating Expenses for 3 consecutive years, with $4.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses fell 28.52% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $22.5 million (down 10.59% YoY), while the FY2025 annual figure was $22.5 million, down 10.59% from the prior year.
- Operating Expenses declined to $4.7 million in Q4 2025 per ACTU's latest filing, from $5.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $7.8 million in Q1 2024 and bottomed at $4.7 million in Q4 2025.
- Historically, Operating Expenses has averaged $6.1 million across 3 years, with a median of $6.0 million in 2025.
- On a YoY basis, Operating Expenses climbed as much as 9.81% in 2025 and fell as far as 28.52% in 2025.
- Actuate Therapeutics' Operating Expenses stood at $7.6 million in 2023, then fell by 13.87% to $6.6 million in 2024, then fell by 28.52% to $4.7 million in 2025.
- Business Quant data shows ACTU's Operating Expenses at $4.7 million in Q4 2025, $5.5 million in Q3 2025, and $6.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 541.02 Mn |
| 10 | Actuate Therapeutics | 28.65 Mn | 28.65 Mn | - | 4.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 5.47 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Mar 31, 2025 | 6.37 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 5.44 Mn |
| Mar 31, 2024 | 7.77 Mn |
| Dec 31, 2023 | 7.62 Mn |
| Sep 30, 2023 | 6.48 Mn |
| Jun 30, 2023 | 5.58 Mn |